ArticleClinical and translational science2025

Pharmacokinetics of SARS-CoV-2 RNA Polymerase Inhibitor Remdesivir in Participants With Moderate and Severe Hepatic Impairment.

Sean Regan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.